A carregar...
Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia
One of the second-generation tyrosine kinase inhibitors (TKIs), nilotinib, is increasingly used for imatinib-resistant or intolerant chronic myeloid leukemia (CML). Nilotinib is considered well tolerated with few side effects including hyperglycemia, hyperbilirubinemia and elevated levels of pancrea...
Na minha lista:
| Publicado no: | Interv Neuroradiol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624406/ https://ncbi.nlm.nih.gov/pubmed/28583043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1591019917710810 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|